Metraipolis › archive › dc_635f997bafcb
SBRT vs HDR Brachytherapy for Intermediate-Risk Prostate Cancer — Europe PMC PMID:41739470
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41739470
- DOI
- 10.1001/jamanetworkopen.2026.0146
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T07:30:28.380Z
- SHA-256 of the archived text
4a4b2335428c2b7287bc0edfa5344d540b7fffa161753f9f976f0dcd38ae43e6- Stable URL of this page
https://metraipolis.com/documento/dc_635f997bafcb
How to cite
SBRT vs HDR Brachytherapy for Intermediate-Risk Prostate Cancer — Europe PMC PMID:41739470 — Europe PMC (en), https://europepmc.org/article/MED/41739470 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_635f997bafcb (Metraipolis archive dc_635f997bafcb, sha256 4a4b2335428c2b7287bc0edfa5344d540b7fffa161753f9f976f0dcd38ae43e6)
BibTeX
@misc{dc635f997bafcb,
title = {SBRT vs HDR Brachytherapy for Intermediate-Risk Prostate Cancer — Europe PMC PMID:41739470},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41739470},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_635f997bafcb; sha256 4a4b2335428c2b7287bc0edfa5344d540b7fffa161753f9f976f0dcd38ae43e6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41739470. Agents can read the archived copy with the MCP tool read_document.